PTC announces FDA acceptance, priority review of NDA for vatiquinone
PTC Therapeutics (PTCT) announced that the U.S. Food and Drug Administration, FDA, has accepted for filing the New Drug Application, NDA, for ...
BioSpace1h
5 Pharma Powerhouses Facing Massive Patent Cliffs—And What They’re Doing About It
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Hosted on MSN2h
Drug Can Stave Off Organ Damage From Lupus
Key Takeaways A newer lupus drug can protect patients from long-term organ damageAnifrolumab (Saphnelo) lowered the risk of ...
Focus: Next generation weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Bayer Receives FDA Endorsement to Accelerate Development of Parkinson Treatment
Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.
WSLS 1010h
Kennedy says panel will examine childhood vaccine schedule after promising not to change it
WASHINGTON – To earn the vote he needed to become the nation's top health official, Robert F. Kennedy Jr. made a special ...
WSLS 1010h
WATCH: FDA approves new method to screen for cervical cancer
Pap smears are a regular part of health care for those at risk of cervical cancer, but for many patients, the test can be uncomfortable or embarrassing.
Hosted on MSN13h
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
WBOC14h
FDA Approves World's Smallest Heart Pump
Not home to watch today's news? Sign up for WBOC's daily headlines to keep up with the latest across Delmarva, sent straight ...
Becker's Hospital Review16h
AI helps Cleveland Clinic uncover new uses for existing drugs
Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...
FiercePharma16h
Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA
Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...
Monthly Prescribing Reference17h
Romvimza Approved for Symptomatic Tenosynovial Giant Cell Tumor
The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...